Frontotemporal Dementia Treatment: Current Symptomatic Therapies and Implications of Recent Genetic, Biochemical, and Neuroimaging Studies

Frontotemporal dementia (FTD) is a common cause of dementia that encompasses 3 clinical subtypes: a behavioral/dysexecutive (frontal) variant and 2 variants with prominent language impairments. There are currently no Food and Drug Administration-approved medications for FTD although symptomatic treatments such as selective serotonin reuptake inhibitors and atypical antipsychotic agents are frequently used to manage behavioral abnormalities associated with this disorder. Evidence for the use of currently available symptomatic treatments in each FTD clinical subtype is reviewed. In addition, the implications of new genetic and neuropathologic information about FTD for the design of future clinical trials and the eventual development of FTD-specific disease-modifying treatments are discussed.

[1]  P. Bittencourt,et al.  [Semantic dementia]. , 2020, Arquivos de neuro-psiquiatria.

[2]  J. Ashburner,et al.  Atrophy progression in semantic dementia with asymmetric temporal involvement: A tensor-based morphometry study , 2009, Neurobiology of Aging.

[3]  G. Linazasoro,et al.  IMAGING β-AMYLOID BURDEN IN AGING AND DEMENTIA , 2008, Neurology.

[4]  J. Morris,et al.  TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. , 2007, The American journal of pathology.

[5]  Colin Studholme,et al.  Deformation-based morphometry reveals brain atrophy in frontotemporal dementia. , 2007, Archives of neurology.

[6]  L. Mucke,et al.  Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model , 2007, Science.

[7]  F. LaFerla,et al.  Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. , 2007, The American journal of pathology.

[8]  D. Dickson,et al.  TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease , 2007, Annals of neurology.

[9]  G. Schellenberg,et al.  A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology. , 2007, Brain : a journal of neurology.

[10]  John Ashburner,et al.  A tensor based morphometry study of longitudinal gray matter contraction in FTD , 2007, NeuroImage.

[11]  B. Miller,et al.  11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration , 2007, Neurology.

[12]  Andrew Kertesz,et al.  The Diagnosis and Course of Frontotemporal Dementia , 2007, Alzheimer disease and associated disorders.

[13]  P. Pietrini,et al.  Clinicopathologic features of frontotemporal dementia with Progranulin sequence variation , 2007, Neurology.

[14]  Cam Patterson,et al.  The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. , 2007, The Journal of clinical investigation.

[15]  M. Freedman.  Frontotemporal Dementia: Recommendations for Therapeutic Studies, Designs, and Approaches , 2007, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[16]  D. Dickson,et al.  Journal of Neuroinflammation BioMed Central Review , 2006 .

[17]  Matthias J. Müller,et al.  Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism , 2007, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[18]  G. Borasio,et al.  Inappropriate sexual behaviour in a case of ALS and FTD: Successful treatment with sertraline , 2007, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[19]  J. Morris,et al.  Neuropathologic Heterogeneity in HDDD1: A Familial Frontotemporal Lobar Degeneration With Ubiquitin-positive Inclusions and Progranulin Mutation , 2007, Alzheimer disease and associated disorders.

[20]  John R. Hodges,et al.  Social reasoning, emotion and empathy in frontotemporal dementia , 2006, Neuropsychologia.

[21]  J. Hardy,et al.  Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis–frontotemporal dementia phenotypes , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[22]  B L Miller,et al.  Behavioral features in semantic dementia vs other forms of progressive aphasias , 2006, Neurology.

[23]  N. Schuff,et al.  Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. , 2006, Brain : a journal of neurology.

[24]  H. Feldman,et al.  The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. , 2006, Brain : a journal of neurology.

[25]  M. Nishikawa.  [Optimization of in-vivo gene transfer through regulating biological response to vectors]. , 2006, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[26]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[27]  P. Pietrini,et al.  Characteristics of frontotemporal dementia patients with a Progranulin mutation , 2006, Annals of neurology.

[28]  C. Duijn,et al.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.

[29]  S. Melquist,et al.  Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17 , 2006, Nature.

[30]  Wen-Lang Lin,et al.  Deletion of the Ubiquitin Ligase CHIP Leads to the Accumulation, But Not the Aggregation, of Both Endogenous Phospho- and Caspase-3-Cleaved Tau Species , 2006, The Journal of Neuroscience.

[31]  Jennifer L. Whitwell,et al.  Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. , 2006, Brain : a journal of neurology.

[32]  Jennifer Farmer,et al.  Frontotemporal dementia: Clinicopathological correlations , 2006, Annals of neurology.

[33]  Tim D. Fryer,et al.  Declarative memory impairments in Alzheimer's disease and semantic dementia , 2006, NeuroImage.

[34]  F. Baas,et al.  Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. , 2006, Brain : a journal of neurology.

[35]  C. Jack,et al.  Frontotemporal dementia and parkinsonism associated with the IVS1+1G->A mutation in progranulin: a clinicopathologic study. , 2006, Brain : a journal of neurology.

[36]  H. Horvitz,et al.  A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia , 2006, Neurology.

[37]  T. Robbins,et al.  Methylphenidate (‘Ritalin’) can Ameliorate Abnormal Risk-Taking Behavior in the Frontal Variant of Frontotemporal Dementia , 2006, Neuropsychopharmacology.

[38]  Joseph James Duffy,et al.  Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP , 2006, Neurology.

[39]  Jordan Grafman,et al.  A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia , 2006, Neurology.

[40]  D. G. Clark,et al.  Early-Onset Dementia: Frequency and Causes Compared to Late-Onset Dementia , 2006, Dementia and Geriatric Cognitive Disorders.

[41]  J. Neuhaus,et al.  Comparison of family histories in FTLD subtypes and related tauopathies , 2005, Neurology.

[42]  Guido F. Schauer,et al.  Neuroanatomical correlates of behavioural disorders in dementia. , 2005, Brain : a journal of neurology.

[43]  T. Chow.  Treatment approaches to symptoms associated with frontotemporal degeneration , 2005, Current psychiatry reports.

[44]  K Yaffe,et al.  Frontotemporal dementia progresses to death faster than Alzheimer disease , 2005, Neurology.

[45]  Andrew Kertesz,et al.  The evolution and pathology of frontotemporal dementia. , 2005, Brain : a journal of neurology.

[46]  Karalyn Patterson,et al.  The pathological basis of semantic dementia. , 2005, Brain : a journal of neurology.

[47]  B. Miller,et al.  Frontotemporal lobar degeneration: demographic characteristics of 353 patients. , 2005, Archives of neurology.

[48]  J. Shapira,et al.  Stereotypical movements and frontotemporal dementia , 2005, Movement disorders : official journal of the Movement Disorder Society.

[49]  W. Noble,et al.  Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Jennifer Farmer,et al.  Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease , 2005, Annals of neurology.

[51]  B. L. Miller,et al.  The natural history of temporal variant frontotemporal dementia , 2005, Neurology.

[52]  Steven G Potkin,et al.  A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease , 2005, Nature Medicine.

[53]  John Hodges,et al.  Pathologically proven frontotemporal dementia presenting with severe amnesia. , 2005, Brain : a journal of neurology.

[54]  J. Hodges,et al.  Clinicopathological correlates in frontotemporal dementia , 2004, Annals of neurology.

[55]  F. Pasquier,et al.  Frontotemporal Dementia: A Randomised, Controlled Trial with Trazodone , 2004, Dementia and Geriatric Cognitive Disorders.

[56]  M. Primeau,et al.  Quantitative Electroencephalography in Frontotemporal Dementia with Methylphenidate Response: A Case Study , 2004, Clinical EEG and neuroscience.

[57]  B. Sahakian,et al.  Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial , 2004, Psychopharmacology.

[58]  B L Miller,et al.  Behavioral disorders in the frontal and temporal variants of frontotemporal dementia , 2004, Neurology.

[59]  M. Ikeda,et al.  Efficacy of Fluvoxamine as a Treatment for Behavioral Symptoms in Frontotemporal Lobar Degeneration Patients , 2004, Dementia and Geriatric Cognitive Disorders.

[60]  M. Weiner,et al.  Cognition and anatomy in three variants of primary progressive aphasia , 2004, Annals of neurology.

[61]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[62]  J. Hodges,et al.  Survival in frontotemporal dementia , 2003, Neurology.

[63]  A. Bava,et al.  Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: A 24-month follow-up of 68 patients , 2003, American journal of Alzheimer's disease and other dementias.

[64]  Norbert Schuff,et al.  Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia. , 2003, Archives of neurology.

[65]  J. Hodges,et al.  Staging disease severity in pathologically confirmed cases of frontotemporal dementia , 2003, Neurology.

[66]  Joel H Kramer,et al.  Double dissociation of social functioning in frontotemporal dementia , 2003, Neurology.

[67]  Nick C Fox,et al.  Vulnerability to neuroleptic side effects in frontotemporal lobar degeneration , 2003, International journal of geriatric psychiatry.

[68]  A. Bava,et al.  Frontotemporal Dementia: Paroxetine as a Possible Treatment of Behavior Symptoms , 2002, European Neurology.

[69]  J R Hodges,et al.  Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer’s disease , 2002, Journal of neurology, neurosurgery, and psychiatry.

[70]  N. Schuff,et al.  Emotion comprehension in the temporal variant of frontotemporal dementia. , 2002, Brain : a journal of neurology.

[71]  J. Hodges,et al.  Progressive prosopagnosia associated with selective right temporal atrophy: a new syndrome? , 2002 .

[72]  A. Bava,et al.  Effects of selegiline on fronto‐temporal dementia: a neuropsychological evaluation , 2002, International journal of geriatric psychiatry.

[73]  Nick C Fox,et al.  Rates of global and regional cerebral atrophy in AD and frontotemporal dementia , 2001, Neurology.

[74]  B Miller,et al.  Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. , 2001, Archives of neurology.

[75]  J R Hodges,et al.  Episodic memory: insights from semantic dementia. , 2001, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[76]  K. Boone,et al.  Neuroanatomy of the self , 2001, Neurology.

[77]  R. J. Perry,et al.  Behavior and treatment in frontotemporal dementia , 2001, Neurology.

[78]  M. Hutton.  Missense and splice site mutations in tau associated with FTDP-17: Multiple pathogenic mechanisms , 2001, Neurology.

[79]  B. L. Miller,et al.  The influence of right frontotemporal dysfunction on social behavior in frontotemporal dementia , 2001, Neurology.

[80]  J. Hodges.  Frontotemporal dementia (Pick’s disease): Clinical features and assessment , 2001, Neurology.

[81]  A. Kertesz,et al.  The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia , 2000, Neurology.

[82]  R. Curtis,et al.  Case of pick's central lobar atrophy with apparent stabilization of cognitive decline after treatment with risperidone. , 2000, Journal of clinical psychopharmacology.

[83]  J. Hodges,et al.  Insights from semantic dementia on the relationship between episodic and semantic memory , 2000, Neuropsychologia.

[84]  C. Cotman,et al.  Clinical and pathological evidence for a frontal variant of Alzheimer disease. , 1999, Archives of neurology.

[85]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[86]  J R Hodges,et al.  Early diagnosis of the frontal variant of frontotemporal dementia: how sensitive are standard neuroimaging and neuropsychologic tests? , 1999, Neuropsychiatry, neuropsychology, and behavioral neurology.

[87]  J R Hodges,et al.  Dementia and aphasia in motor neuron disease: an underrecognised association? , 1998, Journal of neurology, neurosurgery, and psychiatry.

[88]  B L Miller,et al.  Emergence of artistic talent in frontotemporal dementia , 1998, Neurology.

[89]  D. Benson,et al.  Behavioral Phenomenology in Alzheimer's Disease, Frontotemporal Dementia, and Late-Life Depression: A Retrospective Analysis , 1997, Journal of geriatric psychiatry and neurology.

[90]  Gerald L. Russell,et al.  The temporal variant of frontotemporal dementia. , 1997, Brain : a journal of neurology.

[91]  J. Swartz,et al.  Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors. , 1997, The Journal of clinical psychiatry.

[92]  J. Cummings,et al.  The Neuropsychiatric Inventory , 1997, Neurology.

[93]  M. Trabucchi,et al.  Alzheimer disease and frontotemporal dementia. , 1997, Archives of neurology.

[94]  A. Kertesz,et al.  Frontal Behavioral Inventory: Diagnostic Criteria for Frontal Lobe Dementi , 1997, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[95]  B L Miller,et al.  Alzheimer disease and frontotemporal dementias. Behavioral distinctions. , 1996, Archives of neurology.

[96]  B L Miller,et al.  Dietary changes, compulsions and sexual behavior in frontotemporal degeneration. , 1995, Dementia.

[97]  John W. Miller,et al.  Secondarily generalized seizures , 1995, Neurology.

[98]  R. Petersen,et al.  Rapidly progressive aphasic dementia and motor neuron disease , 1993, Annals of neurology.

[99]  D. Royall,et al.  Bedside Assessment of Executive Cognitive Impairment: The Executive Interview , 1992, Journal of the American Geriatrics Society.

[100]  J. Hardy,et al.  Progranulin mutations and ALS or ALS-FTD phenotypes , 2007 .

[101]  Nancy Johnson,et al.  Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. , 2007, Archives of neurology.

[102]  M. Mendez,et al.  Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. , 2007, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[103]  B. Miller,et al.  Dysphagia in patients with frontotemporal lobar dementia. , 2007, Archives of neurology.

[104]  T. Shimomura,et al.  [Stereotyped behaviors and compulsive complaints of pain improved by fluvoxamine in two cases of frontotemporal dementia]. , 2006, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica.

[105]  Alexandra Flemming,et al.  Infectious disease: Unravelling SARS lethality , 2005, Nature Reviews Drug Discovery.

[106]  Katsuji Kobayashi,et al.  [Progressive prosopagnosia associated with selective right temporal lobe atrophy]. , 2004, Nihon rinsho. Japanese journal of clinical medicine.

[107]  Irene Litvan,et al.  Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia , 2003, Annals of neurology.

[108]  J. Cummings,et al.  Repetitive and compulsive behavior in frontal lobe degenerations. , 1994, The Journal of neuropsychiatry and clinical neurosciences.